$BNGO
Bionano Genomics, Inc. Stock $bngo

$bngo Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-K Financial Statement

#000141169020000006 Filed on March 10, 2020

Income Statement

Concept	2020 Q1	2019 Q4	2019
Revenue	$1.136M	$2.789M	$10.13M
YoY Change	-38.69%	-30.51%	-15.59%
Cost Of Revenue	$856.0K	$1.691M	$6.768M
YoY Change	-25.37%	-43.42%	-22.31%
Gross Profit	$280.0K	$1.098M	$3.361M
YoY Change	-60.34%	7.11%	2.19%
Gross Profit Margin	24.65%	39.38%	33.18%
Selling, General & Admin	$7.368M	$5.860M	$20.16M
YoY Change	53.79%	27.39%	41.74%
% of Gross Profit	2631.43%	533.52%	599.62%
Research & Development	$2.674M	$2.400M	$9.081M
YoY Change	27.33%	-4.76%	-4.25%
% of Gross Profit	955.0%	218.51%	270.16%
Depreciation & Amortization	$296.0K	$320.0K	$1.128M
YoY Change	9.63%	113.33%	-14.59%
% of Gross Profit	105.71%	29.13%	33.55%
Operating Expenses	$10.04M	$8.260M	$29.24M
YoY Change	45.73%	16.01%	23.34%
Operating Profit	-$9.762M	-$7.162M	-$25.87M
YoY Change	57.83%	17.51%	26.74%
Interest Expense	$761.0K	-$870.0K	$2.286M
YoY Change	178.75%	222.22%	65.54%
% of Operating Profit
Other Income/Expense, Net	-$743.0K	$550.0K	-$3.919M
YoY Change	-55.29%	-1475.0%	-302.62%
Pretax Income	-$10.51M	-$7.890M	-$29.79M
YoY Change	33.87%	23.28%	61.22%
Income Tax	$5.000K	$10.00K	$21.05K
% Of Pretax Income
Net Earnings	-$10.51M	-$7.900M	-$29.82M
YoY Change	33.85%	23.22%	61.19%
Net Earnings / Revenue	-925.18%	-283.24%	-294.34%
Basic Earnings Per Share
Diluted Earnings Per Share	-$295.5K	-$282.8K	-$1.991M
COMMON SHARES
Basic Shares Outstanding	37.75M shares	26.49M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q1	2019 Q4	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.100M	$17.30M	$17.31M
YoY Change	-61.06%	4.85%	4.78%
Cash & Equivalents	$8.144M	$17.30M	$17.31M
Short-Term Investments
Other Short-Term Assets	$1.100M	$457.1K	$1.170M
YoY Change	-19.94%	18.99%	27.17%
Inventory	$3.611M	$3.444M	$3.440M
Prepaid Expenses
Receivables	$4.115M	$6.334M	$6.330M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$16.98M	$28.26M	$28.26M
YoY Change	-39.38%	22.73%	22.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.120M	$1.950M	$1.950M
YoY Change	37.92%	9.7%	9.55%
Goodwill		$0.00
YoY Change
Intangibles		$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change
Total Long-Term Assets	$2.120M	$1.950M	$1.950M
YoY Change	37.92%	9.7%	10.17%
TOTAL ASSETS
Total Short-Term Assets	$16.98M	$28.26M	$28.26M
Total Long-Term Assets	$2.120M	$1.950M	$1.950M
Total Assets	$19.10M	$30.21M	$30.21M
YoY Change	-35.36%	21.79%	21.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.176M	$2.699M	$2.700M
YoY Change	264.71%	99.68%	100.0%
Accrued Expenses	$2.725M	$3.225M	$2.960M
YoY Change	-24.91%	11.22%	2.07%
Deferred Revenue	$318.0K	$358.0K
YoY Change		32.1%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$16.97M	$20.08M	$20.08M
YoY Change
Total Short-Term Liabilities	$23.19M	$26.37M	$26.37M
YoY Change	391.95%	482.97%	483.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$0.00	$44.48K	$230.0K
YoY Change	-100.0%	-94.5%	-79.28%
Total Long-Term Liabilities	$0.00	$44.48K	$230.0K
YoY Change	-100.0%	-99.55%	-97.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.19M	$26.37M	$26.37M
Total Long-Term Liabilities	$0.00	$44.48K	$230.0K
Total Liabilities	$23.32M	$26.59M	$26.59M
YoY Change	-1.55%	81.34%	81.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$113.1M	-$102.6M
YoY Change	40.28%	41.01%
Common Stock	$108.9M	$106.2M
YoY Change	25.89%	28.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.213M	$3.613M	$3.610M
YoY Change
Total Liabilities & Shareholders Equity	$19.10M	$30.21M	$30.21M
YoY Change	-35.36%	21.79%	21.81%

Cashflow Statement

Concept	2020 Q1	2019 Q4	2019
OPERATING ACTIVITIES
Net Income	-$10.51M	-$7.900M	-$29.82M
YoY Change	33.85%	23.22%	61.19%
Depreciation, Depletion And Amortization	$296.0K	$320.0K	$1.128M
YoY Change	9.63%	113.33%	-14.59%
Cash From Operating Activities	-$8.032M	-$9.480M	-$29.50M
YoY Change	22.59%	131.78%	47.92%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$20.00K	$61.06K
YoY Change		100.0%	-81.59%
Acquisitions			$0.00
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$20.00K	-$61.06K
YoY Change		100.0%	-81.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.135M	18.59M	$30.38M
YoY Change	-110.45%	-62066.67%	-15.09%
NET CHANGE
Cash From Operating Activities	-$8.032M	-9.480M	-$29.50M
Cash From Investing Activities	$0.00	-20.00K	-$61.06K
Cash From Financing Activities	-$1.135M	18.59M	$30.38M
Net Change In Cash	-$9.167M	9.090M	$788.6K
YoY Change	-312.84%	-320.1%	-94.91%
FREE CASH FLOW
Cash From Operating Activities	-$8.032M	-$9.480M	-$29.50M
Capital Expenditures	$0.00	-$20.00K	$61.06K
Free Cash Flow	-$8.032M	-$9.460M	-$29.56M
YoY Change	22.59%	131.86%	45.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	bngo	Operating Leases Future Minimum Payments Due Next Twelve Months Net OperatingLeasesFutureMinimumPaymentsDueNextTwelveMonthsNet	438078	USD
CY2018Q4	bngo	Accrued Expense Reimbursements Current AccruedExpenseReimbursementsCurrent	133697	USD
CY2019Q4	bngo	Accrued Expense Reimbursements Current AccruedExpenseReimbursementsCurrent	187516	USD
CY2018Q4	bngo	Accrued Inventory Current AccruedInventoryCurrent	0	USD
CY2019Q4	bngo	Accrued Inventory Current AccruedInventoryCurrent	191721	USD
CY2018	bngo	Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock Warrant Liability AdjustmentsToAdditionalPaidInCapitalReclassificationOfConvertiblePreferredStockWarrantLiability	84676	USD
CY2019	bngo	Adjustmentsto Additional Paidin Capital Reduction In Warrant Exercise Price For Covenant Waiver AdjustmentstoAdditionalPaidinCapitalReductionInWarrantExercisePriceForCovenantWaiver	45787	USD
CY2019	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Exercised In Period Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueExercisedInPeriodOfWarrantsOrRights	10457345	USD
CY2019Q4	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	7932689	USD
CY2019	bngo	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Canceled In Period ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsCanceledInPeriod	59.90
CY2019	bngo	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised In Period ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisedInPeriod	0.07
CY2019	bngo	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Granted In Period ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGrantedInPeriod	0.57
CY2018	bngo	Class Of Warrant Or Right Expense Recognized ClassOfWarrantOrRightExpenseRecognized	165000	USD
CY2019	bngo	Class Of Warrant Or Right Number Of Securities Canceled In Period ClassOfWarrantOrRightNumberOfSecuritiesCanceledInPeriod	1502	shares
CY2019	bngo	Class Of Warrant Or Right Number Of Securities Exercised In Period ClassOfWarrantOrRightNumberOfSecuritiesExercisedInPeriod	11678458	shares
CY2019	bngo	Class Of Warrant Or Right Number Of Securities Granted In Period ClassOfWarrantOrRightNumberOfSecuritiesGrantedInPeriod	32023503	shares
CY2018	bngo	Class Of Warrant Or Right Reduction Exercise Price For Covenant Waiver ClassOfWarrantOrRightReductionExercisePriceForCovenantWaiver	0	USD
CY2019	bngo	Class Of Warrant Or Right Reduction Exercise Price For Covenant Waiver ClassOfWarrantOrRightReductionExercisePriceForCovenantWaiver	45787	USD
CY2019	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Granted In Period Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermGrantedInPeriodOfWarrantsOrRights	P4Y10M2D
CY2018	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P4Y8M1D
CY2019	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P4Y9M25D
CY2018	bngo	Conversion Of Preferred Stock Warrants Into Common Stock And Common Stock Warrants ConversionOfPreferredStockWarrantsIntoCommonStockAndCommonStockWarrants	84676	USD
CY2019	bngo	Conversion Of Preferred Stock Warrants Into Common Stock And Common Stock Warrants ConversionOfPreferredStockWarrantsIntoCommonStockAndCommonStockWarrants	0	USD
CY2018	bngo	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	838137	USD
CY2019	bngo	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	0	USD
CY2019	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	141706	USD
CY2018	bngo	Equity Issued With Debt Classified As Liability EquityIssuedWithDebtClassifiedAsLiability	176813	USD
CY2019	bngo	Equity Issued With Debt Classified As Liability EquityIssuedWithDebtClassifiedAsLiability	831619	USD
CY2018	bngo	Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities	400000	USD
CY2019	bngo	Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities	0	USD
CY2019Q4	bngo	Long Term Debt Minimum Loan Payments Including Interest LongTermDebtMinimumLoanPaymentsIncludingInterest	20473436	USD
CY2018	bngo	Noncash Debt Extinguishment NoncashDebtExtinguishment	0	USD
CY2019	bngo	Noncash Debt Extinguishment NoncashDebtExtinguishment	521496	USD
CY2018	bngo	Noncash Interest Expense NoncashInterestExpense	750474	USD
CY2019	bngo	Noncash Interest Expense NoncashInterestExpense	883269	USD
CY2019Q4	bngo	Operating Leases Future Minimum Payments Due In Four Years Net OperatingLeasesFutureMinimumPaymentsDueInFourYearsNet	666411	USD
CY2019Q4	bngo	Operating Leases Future Minimum Payments Due Net OperatingLeasesFutureMinimumPaymentsDueNet	3779349	USD
CY2019Q4	bngo	Operating Leases Future Minimum Payments Duein Five Year OperatingLeasesFutureMinimumPaymentsDueinFiveYear	696388	USD
CY2019Q4	bngo	Operating Leases Future Minimum Payments Duein Three Years Net OperatingLeasesFutureMinimumPaymentsDueinThreeYearsNet	638740	USD
CY2019Q4	bngo	Operating Leases Future Minimum Payments Duein Two Years Net OperatingLeasesFutureMinimumPaymentsDueinTwoYearsNet	611061	USD
CY2019Q4	bngo	Operating Leases Future Minimum Payments Receivablen Year Five And Thereafter OperatingLeasesFutureMinimumPaymentsReceivablenYearFiveAndThereafter	0	USD
CY2019Q4	bngo	Operating Leases Net Minimum Payment Due Thereafter OperatingLeasesNetMinimumPaymentDueThereafter	728671	USD
CY2019	bngo	Purchase Obligation Continuous Purchase Period PurchaseObligationContinuousPurchasePeriod	P3M
CY2019	bngo	Purchase Obligation Contract Termination Period PurchaseObligationContractTerminationPeriod	P90D
CY2019	bngo	Purchase Obligation Initial Purchase Period PurchaseObligationInitialPurchasePeriod	P2Y
CY2019	bngo	Stock Issued During Period Value Covenant Waiver StockIssuedDuringPeriodValueCovenantWaiver	504167	USD
CY2019	bngo	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	9396736	USD
CY2018	bngo	Transfer Of Instruments From Property And Equipment To Inventory TransferOfInstrumentsFromPropertyAndEquipmentToInventory	242831	USD
CY2019	bngo	Transfer Of Instruments From Property And Equipment To Inventory TransferOfInstrumentsFromPropertyAndEquipmentToInventory	0	USD
CY2018	bngo	Transfer Of Instruments To Property And Equipment From Inventory TransferOfInstrumentsToPropertyAndEquipmentFromInventory	0	USD
CY2019	bngo	Transfer Of Instruments To Property And Equipment From Inventory TransferOfInstrumentsToPropertyAndEquipmentFromInventory	1266015	USD
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001411690
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37752469	shares
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q2	dei	Entity Public Float EntityPublicFloat	26700000	USD
CY2019	dei	Entity Registrant Name EntityRegistrantName	BioNano Genomics, Inc
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1351736	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2699153	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4514333	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6333963	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2900129	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3225431	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	195854	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	213514	USD
CY2018Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	268319	USD
CY2019Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	266282	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5162364	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6273466	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82898775	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	106187789	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	201789	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1193873	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1346023	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	165000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	629830	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1193873	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1346023	USD
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24406050	shares
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	270171	USD
CY2019Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	841449	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	554867	USD
CY2018	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	225052	USD
CY2019	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	225052	USD
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5345354	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25769462	shares
CY2018Q4	us-gaap	Assets Assets	24802421	USD
CY2019Q4	us-gaap	Assets Assets	30207866	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	23025119	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	28258241	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3150	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16522729	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17311373	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1021897	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16522729	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17311373	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15500832	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	788644	USD
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.32
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.76
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4062507	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10055072	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34274469	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10055072	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34274469	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1004	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	3427	USD
CY2018	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	211697	USD
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1813430	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3068332	USD
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2988115	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8711326	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1147042	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1555246	USD
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	270998	USD
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	357492	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2375100	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1690759	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6768147	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	5262497	USD
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	5588800	USD
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	5729212	USD
CY2018Q4	us-gaap	Costs And Expenses CostsAndExpenses	7123985	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	23704494	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	6890713	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	7463697	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	6622993	USD
CY2019Q4	us-gaap	Costs And Expenses CostsAndExpenses	8258864	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	29236267	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	13955	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	19492	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15511	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	21048	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1556	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1556	USD
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	14898327	USD
CY2019	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2018Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10000000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	21971391	USD
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	970626	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1886446	USD
CY2018Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	304467	USD
CY2019Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	182648	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41407887	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	48194877	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35104728	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	41780806	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1725577	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1406893	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4577582	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5007178	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41407887	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48194877	USD
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	272507	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	381670	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1320521	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1127850	USD
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.61
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.99
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1832630	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1805357	USD
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2512964.1	USD
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3991081	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-11918	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-342164	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1333496	USD
CY2018	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-18515638	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-29851428	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18480881	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29794022	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	34757	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	57406	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15511	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21048	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5617471	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6786990	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3880985	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6256953	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	95852	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	449958	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-476179	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-529351	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	502511	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	429596	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-954377	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1362397	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	900119	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2374497	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-247402	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-73910	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	418984	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3641017	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-152012	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	245046	USD
CY2018	us-gaap	Interest Expense InterestExpense	1381024	USD
CY2019	us-gaap	Interest Expense InterestExpense	2286196	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	700353	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	1277184	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9029374	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35776395	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30379420	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-331716	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61056	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19943847	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29529720	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29500000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-3847362	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24802421	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-3311476	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-4926097	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-6411457	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-18496392	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-7851743	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-7664566	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30207866	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4522863	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26367021	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	9029374	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	20084945	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	20084945	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5000000	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2111253	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	7926346	USD
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5435837	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	125743	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	907089	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2492713	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	1068557	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	3443559	USD
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	161468	USD
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	950846	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	1287000	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2018	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	165000	USD
CY2019	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2018Q4	us-gaap	Liabilities Liabilities	14665070	USD
CY2019Q4	us-gaap	Liabilities Liabilities	26594148	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6398166	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-7900595	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-29815070	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1934204	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	808366	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44479	USD
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3919116	USD
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-20415085	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-25874906	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4243683	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	902412	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	696388	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	666411	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	638740	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	611061	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	728671	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	464334	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	464334	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	0	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	0	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	0	USD
CY2019Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	0	USD
CY2018	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	35176	USD
CY2019	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	422116	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	556321	USD
CY2019	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	171796	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	469629	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	435298	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	384131	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	457062	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-115464	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2018	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	333689	USD
CY2019	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	299424	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	331716	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61056	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	919500	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1169346	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1768485	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3390009	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-262000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	554867	USD
CY2019Q4	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	165000	USD
CY2018	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	3615117	USD
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7447571	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10812000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9484163	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9080891	USD
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.66
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72762428	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102577498	USD
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	460684	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	302433	USD
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5113072	USD
CY2018	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	19389978	USD
CY2019	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	19556464	USD
CY2018	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	23830489	USD
CY2019	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	19134424	USD
CY2019Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	18000000	USD
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3499	USD
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	860871	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-18496392	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-29815070	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6939666	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8223091	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1777302	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1949625	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2828704	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4013537	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12000735	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1852746	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2174635	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3312997	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2789130	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10129508	USD
CY2019	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	3- to 12-month
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	540140	USD
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.31
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.03
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14220331	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	319026	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20155376	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	1193873	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1346023	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.621
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.667
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.029
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.024
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y2M12D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y1M6D
CY2018	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	504167	USD
CY2019	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	165402	shares
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	115464	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	141706	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10959535	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3499	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	65864	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-50227211	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10137351	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3613718	USD
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.5
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0467
CY2018Q4	us-gaap	Supplies Supplies	74685	USD
CY2019Q4	us-gaap	Supplies Supplies	409851	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3018563	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3389136	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3708162	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	370573	USD
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7077126	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14977901	shares
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Credit Risks</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist primarily of cash and cash equivalents and accounts receivable. The Company maintains deposits in federally insured major financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s customers are located throughout the world. The Company generally does not require collateral from its customers, but it performs credit evaluations of their financial condition. More information on accounts receivable is contained in the paragraph titled “Accounts Receivable” below. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sources of Materials and Products</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The materials and components for the Company’s product offerings are currently obtained from single or limited sources. The Company competes with other companies for production capacity, therefore, the Company is exposed to a risk of inventory being unavailable at acceptable prices, or at all, if suppliers are unable (or decide) to provide sufficient levels of materials and components and the Company is unable to identify alternative suppliers. </font></div></div>
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company’s revenue recognition for multiple performance obligation arrangements, valuations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets, warranty reserves, certain accrued expenses, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company’s net deferred tax assets and related valuation allowances. Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.</font></div></div>

Files In Submission

Name	View Source	Status
0001411690-20-000006-index-headers.html	Edgar Link	pending
0001411690-20-000006-index.html	Edgar Link	pending
0001411690-20-000006.txt	Edgar Link	pending
0001411690-20-000006-xbrl.zip	Edgar Link	pending
bngo-20191231.xml	Edgar Link	completed
bngo-20191231.xsd	Edgar Link	pending
bngo-20191231_cal.xml	Edgar Link	unprocessable
bngo-20191231_def.xml	Edgar Link	unprocessable
bngo-20191231_lab.xml	Edgar Link	unprocessable
bngo-20191231_pre.xml	Edgar Link	unprocessable
bngo-ex1049x20191231.htm	Edgar Link	pending
bngo-ex231x20191231.htm	Edgar Link	pending
bngo-ex311x20191231.htm	Edgar Link	pending
bngo-ex321x20191231.htm	Edgar Link	pending
bngo-ex416x20191231.htm	Edgar Link	pending
bngo10k-20191231.htm	Edgar Link	pending
bngoinnovatusloanamen.jpg	Edgar Link	pending
chipa03.jpg	Edgar Link	pending
dnaa03.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
grapha03.jpg	Edgar Link	pending
instrumenta03.jpg	Edgar Link	pending
kita03.jpg	Edgar Link	pending
productsa03.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
saphyra03.jpg	Edgar Link	pending
sensitivitya03.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
solutionsa03.jpg	Edgar Link	pending
variationsa03.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNGO
Bionano Genomics, Inc. Stock $bngo

2020 Q1 Form 10-K Financial Statement

#000141169020000006 Filed on March 10, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO Bionano Genomics, Inc. Stock $bngo

2020 Q1 Form 10-K Financial Statement

#000141169020000006 Filed on March 10, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO
Bionano Genomics, Inc. Stock $bngo